Medical technology company Integer Holdings (NYSE:ITGR) reported Q1 CY2025 results exceeding the market’s revenue expectations , with sales up 7.3% year on year to $437.4 million. The company expects the full year’s revenue to be around $1.86 billion, close to analysts’ estimates. Its non-GAAP profit of $1.31 per share was 5.5% above analysts’ consensus estimates.

Is now the time to buy ITGR? Find out in our full research report (it’s free).

  • Revenue: $437.4 million vs analyst estimates of $428.7 million (7.3% year-on-year growth, 2% beat)

  • Adjusted EPS: $1.31 vs analyst estimates of $1.24 (5.5% beat)

  • Adjusted EBITDA: $91.51 million vs analyst estimates of $88.82 million (20.9% margin, 3% beat)

  • The company reconfirmed its revenue guidance for the full year of $1.86 billion at the midpoint

  • Management raised its full-year Adjusted EPS guidance to $6.33 at the midpoint, a 5.1% increase

  • EBITDA guidance for the full year is $411.5 million at the midpoint, above analyst estimates of $408.2 million

  • Operating Margin: 11.3%, up from 9.5% in the same quarter last year

  • Free Cash Flow was $6.06 million, up from -$5.83 million in the same quarter last year

  • Organic Revenue rose 6.3% year on year, in line with the same quarter last year

  • Market Capitalization: $4.13 billion

Integer Holdings’ Q1 results were driven by continued demand in its cardiovascular and advanced neuromodulation markets, as well as contributions from recent acquisitions. CEO Joe Dziedzic attributed margin improvement to manufacturing efficiencies and disciplined expense management, highlighting that “adjusted operating income grew 14% as we improved our gross margin rate and leveraged our operating expenses.” The company also discussed the planned CEO transition to Peyman Kales, who is credited with key growth in the cardiovascular division.

Looking forward, management’s full-year guidance reflects confidence in sustained organic growth and the benefits of the company’s recent refinancing. CFO Diron Smith cited the impact of interest savings and operational execution, stating, “We are raising our adjusted earnings per share outlook by $0.31 to include the benefit of our March convertible note offering.” The company expects continued above-market growth, margin expansion, and disciplined leverage, even as it navigates external factors such as tariffs and integration of recent acquisitions.

Integer Holdings’ leadership emphasized the impact of segment performance, new capabilities from acquisitions, and ongoing external challenges. The company’s margin and cash flow expansion were supported by targeted investments and strategic execution, while management also discussed industry-wide dynamics affecting customer behavior and manufacturing.